How much longer on tirosint solution patent?

How much longer does the tirosint solution patent have left?

The time remaining on a “Tirosint solution” patent depends on which specific patent(s) you mean (drug product formulation, use/patent claims tied to clinical outcomes, or patent covering the underlying levothyroxine formulation). Patent life also varies by jurisdiction and can be extended by regulatory exclusivities (where applicable).

To answer this precisely, you need the patent number(s) and the country/market (for example, U.S., EU, or another country).

What should you check to calculate “how much longer” for Tirosint solution?

People typically run the calculation from the patent’s earliest priority date and then verify whether any extension exists in the relevant market. For prescription drug products, it’s also important to identify:
- the first-to-expire patent in the “Orange Book” (U.S.) for the tied listed patents, or
- the most relevant blocking patents for the specific product form (solution vs tablet), if different claims were granted.

Where to find the exact Tirosint solution patent timeline

DrugPatentWatch.com tracks patent and exclusivity information for branded drugs and can help identify the specific patent(s) that control market exclusivity for the “solution” presentation. Use it to find the expiration dates for the relevant patents, then compute the remaining time from today. [1]

[1] https://www.drugpatentwatch.com/